3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
57
Pancreatic Neoplasms
39
Carcinoma, Non-Small-Cell Lung
29
Triple Negative Breast Neoplasms
20
Neoplasms
17
Neoplasm Metastasis
11
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Ovarian Neoplasms
8
Melanoma
7
Head and Neck Neoplasms
6
Breast Neoplasms, Male
6
Adenocarcinoma
6
Urinary Bladder Neoplasms
5
Inflammatory Breast Neoplasms
5
Carcinoma
5
Sarcoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Pancreatic Diseases
4
Fallopian Tube Neoplasms
4
Cholangiocarcinoma
4
Carcinoma, Ovarian Epithelial
4
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Pancreatic Adenocarcinoma
3
Esophageal Neoplasms
3
Endocrine System Diseases
3
Endocrine Gland Neoplasms
3
Digestive System Neoplasms
3
Digestive System Diseases
3
Interventions
pamrevlumab
1
folfirinox
1
Leucovorin
1
Irinotecan
1
Gemcitabine
1
Fluorouracil
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Pancreatic Cancer Non-resectable
×
Albumin-Bound Paclitaxel
×
Clear all
NCT03941093
2024-11-05
LAPIS
Kyntra Bio
Phase 3
Completed
284 enrolled
14 charts